Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT02948426 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

NIH

Sponsor class

Stopped Study was closed to accrual due to lack of drug supply.

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Primary Peritoneal Cancer

Interventions

BIOLOGICAL: Autologous Monocytes + ACTIMMUNE + SYLATRON

Sponsor

National Cancer Institute (NCI)